SCHEMBL16670500

SCHEMBL16670500

CC(C)(O)Cc1ccccc1-c1cccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
TDP1 Q9NUW8 1/20 0.40
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
CYP2C9 P11712 2/20 0.39
PPARD Q03181 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
ACP3 P15309 1/20 0.39
SLC22A12 Q96S37 1/20 0.38
CTNNB1 P35222 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
NR1I2 O75469 1/20 0.37
LMNA P02545 1/20 0.37
ADRA2A P08913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6437231 0.85 CYP2C19 (0.50) CYP2C19CYP1A2CYP2D6TDP1CYP2C9
SCHEMBL7608261 0.83 SLC6A2 (0.41) CYP2C19CYP1A2CYP2D6TDP1PPARG
SCHEMBL477544 0.77 PDCD1 (0.47) CYP2C19CYP1A2CYP2D6TDP1CYP2C9
SCHEMBL2992860 0.76 MEN1 (0.49) CYP2C19CYP1A2CYP2D6TDP1CYP2C9
SCHEMBL808870 0.74 TDP1 (0.53) CYP2C19CYP1A2CYP2D6TDP1CYP2C9
SCHEMBL16670501 0.73 HDAC4 (0.45) SLC22A12GPR84SLC6A2SLC6A4
SCHEMBL30985289 0.73 HDAC4 (0.45) SLC22A12GPR84SLC6A2SLC6A4
Alcohol SCHEMBL7737056 0.73 PPARG (0.47) CYP2C19CYP1A2TDP1PPARGPPARA
SCHEMBL1537099 0.73 CYP1A2 (0.44) CYP2C19CYP1A2CYP2D6TDP1CYP2C9
SCHEMBL10010552 0.73 PPARG (0.42) CYP2C19CYP1A2PPARGPPARACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113501778-B Blue light-emitting compound 株式会社LG化学 2024-06-14 CN disclosed
CN-113501778-A Blue light-emitting compound 株式会社LG化学 2021-10-15 CN disclosed
US-9711731-B2 Blue luminescent compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2017-07-18 US disclosed
US-20160254450-A1 BLUE LUMINESCENT COMPOUNDS LG CHEM, LTD. (KR) 2016-09-01 US disclosed
CN-105658626-A Blue light-emitting compound E.I.内穆尔杜邦公司 2016-06-08 CN disclosed
WO-2015061198-A1 BLUE LUMINESCENT COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2015-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160254450-A1 BLUE LUMINESCENT COMPOUNDS ARRB1, RORA, IK CYP2C19 2093/4885CYP1A2 348/4885CYP2D6 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.